Compare Amphastar Pharmaceuticals Inc (AMPH) vs Zoom Video Communications, Inc. (ZM) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Zoom Communications (ZM) trades at $89.76, showing modest daily movement with a slight 0.13% decline. The stock maintains bullish technical signals with strong moving average support and trades near pivot point resistance at $91. Fundamentally, Zoom demonstrates robust profitability with 77.4% gross margins and 42% net income margins, while recent Q1 2026 earnings beat expectations. The company continues expanding AI capabilities through acquisitions like Common Room and new Virtual Agent offerings.

Zoom presents a compelling value opportunity trading below analyst consensus targets with 32% upside potential. Strong cash generation, AI integration progress, and strategic Anthropic investment provide catalysts, though competitive pressures from Microsoft and Google remain key risks. Wall Street maintains cautious optimism with mixed analyst ratings reflecting growth execution concerns.